Our findings demonstrate that cepharanthine significantly induces mitochondrial apoptosis in human cervical cancer cells both in vitro and in vivo, as evidenced by the increased expression of cleaved PARP-1 and cleaved caspase-3 proteins, along with an elevated Bax/Bcl-2 ratio. This evidence concerns the gene BCL2 and cervical carcinoma.